Fateme Hamzelouei

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates

Mohammad Hossein Moteallehi-Ardakani, Seyyed Mahmoud Hashemi, Talieh Malekshahabi, 2022, NPJ vaccines.

mRNA-based vaccine candidate COReNAPCIN® induces robust humoral and cellular immunity in mice and non-human primates

Mohammad Hossein Moteallehi-Ardakani, Seyyed Mahmoud Hashemi, Talieh Malekshahabi, 2022, bioRxiv.